COST-EFFECTIVENESS ANALYSIS OF RALTEGRAVIR IN HIV-INFECTED TREATMENT NAIVE PATIENTS IN GREECE

被引：1
|
作者：
Athanasakis, K. [1 ]
Boubouchairopoulou, N. [1 ]
Retsa, M. P. [2 ]
Maiese, E. M. [3 ]
Elbasha, E. H. [4 ]
Kyriopoulos, J. [1 ]
机构：
[1] Natl Sch Publ Hlth, Athens, Greece
[2] MSD Hellas, Athens, Greece
[3] Merck & Co Inc, Whitehouse Stn, NJ USA
[4] Merck & Co Inc, Flourtown, PA USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.2506
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN65
引用
收藏
页码：A675 / A675
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa
    Jacqui Miot
    Trudy Leong
    Simbarashe Takuva
    Andrew Parrish
    Halima Dawood
    [J]. BMC Health Services Research, 21
  • [32] Comparative effectiveness of tenofovir in treatment-naive HIV-infected patients: systematic review and meta-analysis
    Hemkens, Lars G.
    Ewald, Hannah
    Santini-Oliveira, Marilia
    Buehler, Julian-Emanuel
    Vuichard, Danielle
    Schandelmaier, Stefan
    Stoeckle, Marcel
    Briel, Matthias
    Bucher, Heiner C.
    [J]. HIV CLINICAL TRIALS, 2015, 16 (05): : 178 - 189
  • [33] Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults
    Schackman, BR
    Freedberg, KA
    Weinstein, MC
    Losina, E
    Zhang, H
    Goldie, S
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (21) : 2478 - 2486
  • [34] Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: a cost-effectiveness modeling analysis
    Rajasingham, R.
    Meya, D.
    Greene, G.
    Jordan, A.
    Chiller, T.
    Boulware, D.
    Larson, B.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21 : 33 - 34
  • [35] ESOPHAGEAL CANDIDIASIS IN HIV-INFECTED PATIENTS - A DECISION-ANALYSIS TO ASSESS THE COST-EFFECTIVENESS OF ALTERNATIVE MANAGEMENT STRATEGIES
    RABENECK, L
    LAINE, L
    [J]. GASTROENTEROLOGY, 1994, 106 (04) : A22 - A22
  • [36] Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis
    Rajasingham, Radha
    Meya, David B.
    Greene, Gregory S.
    Jordan, Alexander
    Nakawuka, Mina
    Chiller, Tom M.
    Boulware, David R.
    Larson, Bruce A.
    [J]. PLOS ONE, 2019, 14 (01):
  • [37] COST-EFFECTIVENESS OF DOLUTEGRAVIR IN HIV-1 TREATMENT-NAIVE PATIENTS IN RUSSIA
    Piercy, J.
    Jakubanis, R.
    Chounta, V
    Bukin, E.
    Kovalchuk, N.
    Punekar, Y. S.
    Holbrook, T.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A788 - A788
  • [38] Cost-effectiveness analysis of antiretroviral drugs for treatment-naive HIV infection in China
    Li, Min
    Cao, Yuxin
    Huang, Hao
    Qin, Gang
    Chu, Minjie
    Zou, Meiyin
    Zhuang, Xun
    [J]. BMC PUBLIC HEALTH, 2023, 23 (01)
  • [39] Cost-effectiveness analysis of antiretroviral drugs for treatment-naive HIV infection in China
    Min Li
    Yuxin Cao
    Hao Huang
    Gang Qin
    Minjie Chu
    Meiyin Zou
    Xun Zhuang
    [J]. BMC Public Health, 23
  • [40] Therapeutic drug monitoring of raltegravir in HIV-infected patients
    Gouguet, C.
    Bregigeon, S.
    Pissier, C.
    Quaranta, S.
    Lacarelle, B.
    Solas, C.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 462 - 463
12345